A high titer retroviral vector containing the cDNA of human estrogen receptor (hER) was generated and used to transfer the hER gene into the rat 208F cell line. Southern blot analysis showed the integration of the provirus to be at a unique site and that the provirus was intact in the genome of recipient cells. The expression of the integrated hER gene in the infected rat cells was detected by Northern blot analysis and by a functional assay in which the hER gene product stimulated the production of a chloramphenicol acetyl transferase gene under the control of an estrogen-responsive element. These experiments demonstrate the feasibility of using a retroviral vector system to introduce a functional ER gene into cultured cells lacking this receptor. (Molecular Endocrinology 3: 1157-1164, 1989)
INTRODUCTION
Estrogen, like other steroid hormones, acts through specific cellular receptors in its target cells (1 -3) . The receptor is activated by the binding of estrogen, and the resulting hormone-receptor complex, acting as a frans-acting regulatory factor, interacts with a specific DNA sequence, a cis regulatory element termed estrogen-responsive element (ERE). The interaction of estrogen-receptor (ER) complex and ERE results in transcriptional activation (4) . Recently, the human ER (hER) cDNA has been cloned from the human mammary carcinoma cell line MCF-7, and the DNA sequence of this gene has been determined (5) . In addition, the 13 basepair (bp) sequence of the Xenopus laevis vitellogenin gene ERE has been identified (6) . The availability of the receptor gene and its DNA target sequence has greatly facilitated the analysis of estrogen-mediated regulation of gene expression (7) .
Investigations of the ER gene and its target sequence require introducing these DNAs into appropriate target 0888-8809/89/1157-1164$02.00/0 Molecular Endocrinology Copyright © 1989 by The Endocrine Society cells. The use of retrovirus vectors to accomplish this has a number of potential benefits relative to the techniques which have been used to date. 1) A wide range of different cell types (including almost all cultured cell lines) are efficiently infectable by retroviral vectors. This is in contrast to the extreme variability in the ability of different cell types to acquire DNA via transfection.
2) The efficiency of infection approaches 100%. This is in dramatic contrast to the low efficiency with which DNA can be introduced into cells via transfection.
3) The gene of interest can be introduced into a large number of cells at one time. This is in contrast to microinjection which can be used to introduce DNA into only a small number of cells at one time. 4) The number of copies of the gene introduced is small, typically one per infected cell, meaning that artifacts will not be caused by an unnaturally high number of gene copies (e.g. titration out of limiting transcription factors). DNA transfection frequently results in introduction of a high number of copies of the introduced gene. 5) Because the process of retrovirus infection is a specific, enzyme-mediated event, the introduced genes will not usually be altered by rearrangement, but rather will retain the original structure.
Although the construction of an effective retrovirus vector can be laborious, once it has been constructed, its subsequent use is extremely convenient. Because of the high efficiency of infection and the ability to infect large numbers of cells at once, experiments can be done on populations of infected cells days after infection without the need to isolate and propagate clones. In addition to being convenient, the analysis of populations of infected cells eliminates the problem of clone to clone variability. In addition, the use of retrovirus vectors makes some experiments possible which would be otherwise impossible. For example, introduction of genes into cells which might be incompatible with longterm cell survival is possible, since it is not necessary to propagate infected cells before studying them. Finally, the use of retrovirus vectors allows introduction of genes into cells of intact animals (8) , something difficult or impossible to accomplish by other tech-niques. Some of these issues are discussed in more detail in Refs. 9 and 10.
Although a retrovirus vector, once available, is extremely convenient to use, construction of a successful vector can sometimes be problematic (11) (12) (13) (14) (15) (16) . The purpose of the work described here was to determine if retrovirus vectors could be used to introduce an ER gene into cultured cells. We report development of a retrovirus vector capable of introducing the hER gene into cells at high efficiency in a structurally unaltered, form. Further, we demonstrate that this hER gene is expressed and produces a functional ER product capable to stimulating expression of a gene containing the ERE.
RESULTS

Generation of Retroviral Vector Containing hER cDNA
We derived a retrovirus vector containing the hER gene by inserting the cloned hER cDNA (5) into the unique 8g/ll site of pXT1, a plasmid containing the genome of the retrovirus vector XT1 (17) . The resulting plasmid was designated pXTHER (Fig. 1) . The XT1 vector is designed such that genomic RNA and mRNA encoding the bacterial neomycin resistance gene (neo) are the unspliced or spliced RNAs, respectively, resulting from transcription initiating from the viral promoter in the long terminal repeats (LTRs), and that the product of a gene inserted into the Bgltt is expressed from an RNA initiating at any internal thymidine kinase (tk) promoter. Thus, virus resulting from pXTHER would be expected to express both the inserted hER gene as well as the neo gene, conferring resistance to the drug G418.
Helper-free recombinant virus was generated from pXTHER by transfection of the plasmid DNA into the \f/ 2 packaging cell line (18) followed by infection of the PA317 packaging cell line (19) with the resulting supernatants. The infected PA317 cells were selected for G418-resistance and the resulting colonies were pooled. This pooled cell line was designated amXTHER. The titer of XTHER virus produced by amXTHER was about 5 x 10 5 G418-resistant colony forming units/ml (CFU/ml). Because of the design of the PA317 packaging cell line, it was expected that the infected cell line would produce transducing vector virus, but no replication competent helper virus. If even a small amount of helper virus were present, this helper virus would spread throughout this culture resulting in XTHER virus production by these infected cells. Thus, we confirmed the absence of helper virus by testing supernatants of XTHER-infected NIH3T3 cells 4 weeks after infection for production of infectious virus. One milliliter of supernatant from the neomycin-resistant NIH3T3 cells was used to infect both NIH3T3 cells and rat 208F cells. No neomycin-resistant cells were detected. Since the neomycin-resistant NIH3T3 cells were infected with 0.1 ml XTHER virus, and because there was no helper virus present in the 0.1 ml, we conclude that the titer of helper virus was probably less than 10 infectious U/ml.
Analysis of the Proviral Genomes in Infected Rat
208F cells
Rat 208F cells were infected with amXTHER-derived virus and G418-resistant cells were selected. Twelve individual colonies resulting from this selection were picked at random and propagated for further analysis.
DNA was isolated from these 12 lines, digested with one of two different restriction enzymes, and the neoor hER-containing fragments detected by the Southern technique. The first restriction enzyme used, Xho\, has a unique site in the viral construction (Fig. 1A) . Thus, the neo probe should detect one size fragment for each integrated provirus present in the infected cell lines. Ten of the 12 cell lines showed a single unique neohybridization band, and two showed two hybridizing fragments (Fig. 2) . When these two cell lines were recloned and reanalyzed, each was shown to be mixtures of two clones, each containing a single integrated provirus (Fig. 3) . Thus, 14 of 14 clones analyzed were found to have received a single proviral genome. The 14 cell lines described above were digested with the restriction enzyme Xba\, which cuts once in each of the LTR at the ends of the provirus and once within the hER cDNA sequences (Fig. 1A) . This would be expected to produce two hER-hybridizing fragments of 5.1 and 1.3 kilobases (kb) for each cell line containing a structurally normal provirus. Hybridization with an hER probe revealed the expected-sized fragments in DNA from 12 of the cell lines, and smaller fragments in two of the cell lines (Fig. 4) . Both of the cell lines with deleted proviruses produced the expected 1.3 kb fragment, but a second fragment smaller than 5.1 kb. Thus, 12 of 14 infections resulted in insertion of hER sequences which were apparently structurally normal.
Expression of hER mRNA in Rat 208F Cells
The structure of XTHER would predict that it should code for three hER-hybridizing mRNAs; a 6.5 kb RNA 1 2 3 4 5 6 7 8 9 10 11 12 originating from the viral promoter in the LTR, used as the genomic RNA for progeny virus, a 6.2 kb RNA resulting from removal of a 300 bp intron present in the 6.5 kb RNA, responsible for expression of the neo gene product, and a 3.2 kb mRNA initiated from the thymidine kinase {tk) promoter, responsible for expression of the hER gene product. Although all three RNAs should contain hER sequences, only the 3.2 kb RNA could lead to hER synthesis. Thus, it was important to confirm that our vector resulted in production of this 3.2 kb RNA. We analyzed RNA from eight of the cell lines containing normal XTHER proviruses and in all eight cases the 3.2 kb mRNA was produced (Fig. 5) . No hER-hybridizing RNA was found in the control rat 208F cells. Thus, the hER vector we have constructed produced the RNA which would be expected to code for the hER protein product. Although we have not at-tempted to precisely quantify the levels of RNA in the infected Rat208F cells, examination of the data in Fig.  5 indicates that the levels of expression of the 3.2 kb, hER-encoding-RNA are similar in the different clones.
Quantification of ER Protein in Infected Rat208F Cells
Although the amount of hER mRNA we detect in the XTHER-infected cells is similar to what we detect in MCF7 cells (data not shown), it is not necessarily the case that this would result in the same level of hER protein. In order to determine the level of hER protein produced in cells infected with XTHER, we used western dot blots to compare the levels of hER protein in five of the infected cell lines to that observed in MCF7 cells ( Table 1 ).
The levels of hER protein we observed in the infected Rat208F cells was significantly lower than what we observed in MCF7 cells. In fact, of all the cells tested, only MCF7 had a level of hER protein significantly above the background measured in uninfected Rat208F cells at the 95% confidence level. (MCF7 had levels of hER significantly above background at the 99.999% confidence level. One of the cells lines, clone 2, had a level significantly above background at the 90% confidence level.) A level of hER 6.6% that of MCF7 would have been significantly above background. Thus, we conclude that none of the infected cells produced a level of hER more than 6.6% that of MCF7.
Validation of an Assay for Functional hER Product
Recently, several research groups demonstrated that regulation of expression of promoters adjacent to an ERE by endogenous (20) or exogenous (7) ER. This suggested to us that the ERE could be used as a probe to detect the function of newly synthesized hER from the vector-containing rat cells. To this end, we used the plasmid pERE-BLCAT2 (Fig. 1B) as a probe for functional ER. Rat 208F cells were transiently transfected with pERE-BLCAT2 and the amount of CAT produced in the presence or absence of estrogen was measured.
Estrogen stimulation of CAT activity would indicate the presence of functional ER.
We performed a series of control experiments to demonstrate that this assay could be used to specifically detect exogenous estrogen receptors. In these control experiments, pHER91023 (see Materials and Methods) was used as a source of exogenous ER and pERE-chloramphenicol acetyltransfererase (BLCAT2) was used as a source of an estrogen-responsive indicator gene. The ER gene contained in pHER91023 is the same one used in the construction of our retrovirus vectors. The results of these experiments are given in Table 2 .
To demonstrate the specificity of the assay, we showed 1) that it is dependent on added estrogen, 2) that other steroids cannot substitute for estrogen, and 3) that it is dependent on an ERE in the regulated gene and 4) that it is dependent on added ER. In order to demonstrate estrogen dependency, it was first necessary to remove endogenous estrogens and phenol red which is capable of stimulating this ER (21) from the medium by absorption to activated charcoal. Although we observed about 15% activity in an assay done in the presence of such stripped medium relative to a mock transfected control, we believe that this represents variability in the assay, as other experiments did not show this background (see for example, Fig. 6 ). Addition of 10~1 0 or 10~9 M estrogen restored approximately 50% of the activity, whereas addition of 10~8 or 10~7 M estrogen restored all of the activity. On this basis, we used 10~8 M estrogen to produce maximal stimulation in all further experiments. These results are consistent with the published equilibrium dissociation constant (K D ) for this receptor (22) . Neither R5020 (a synthetic progesterone) nor dihydrotestosterone (an androgen) were able to substitute for estrogen, showing the hormone dependence to be specific. We demonstrated target DNA specificity by showing that pBLCAT2 (Fig. 1B) , which lacks an ERE, does not produce a high level of activity in the presence of estrogen. Finally, and most importantly, we demonstrated that the assay is dependent on an exogenously added ER gene. Thus, this assay can be used to detect functional, exogenously added ER genes.
Detection of Functional HER Product in Infected Rat 208F Cells
Eight of the XTHER-infected rat cell lines were tested for the presence of functional ER by transient transfection with pERE-BLCAT2 (Fig. 6) . As controls for these experiments, we tested cells transfected with pBLCAT2, which lacks an ERE, or cells cultured in estrogen-free medium. In all cases, the infected cell i100% 2% 4%
1% -1 %
All values are reported relative to a complete assay containing ER, a CAT gene downstream from an ERE, and normal medium (not charcoal stripped) supplemented with 10~8 M estrogen. In all cases, the activity measured in a mock-transfected control was subtracted as background.
lines produced a high level of CAT only in the presence of an estrogen responsive CAT gene and estrogen, in contrast to uninfected Rat 208F cells which do not produce CAT. In the case of three of the lines, we measure CAT activity of the untransfected cell lines and, as expected, found a background level of activity. Thus, eight out of eight lines infected with XTHER produce a functional ER gene.
Cells infected with the parent to our hER-transducing vector, XT-1, do not produce a high level of CAT when transfected with pERE-BLCAT2 in the presence of estrogen (Fig. 6 ). Since XT-1 contains all of the genes present in XTHER except for the hER gene, this result rules out the possibility that our results are due to expression of some gene in the vector other than hER. The fact that eight of eight cell lines infected with XTHER contain functional ER, whereas a line infected with XT-1 does not, rules out the possibility that our results could be due to insertional activation of a cellular gene.
DISCUSSION
The goal of this study was to determine if a retroviral vector could be constructed which would be useful in the analysis of the mechanism of action of the ER. In theory, retroviral vectors have many advantages in these kinds of studies. In practice, many problems have appeared with specific retroviral vectors (11) (12) (13) (14) (15) (16) . We report here the successful construction of a retroviral vector transducing the hER gene.
The expected advantages of using a retroviral vector are: 1) the ability to infect a wide range of different cell types; 2) an efficiency of infection approaching 100%; 3) the ability to infect a large number of cells at one time; 4) introduction of one or a few copies of the gene; and, 5) the fact that structural rearrangements are rare. None of these advantages pertain, of course, if the gene of interest is not efficiently expressed, and that
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Fig. 6. Comparison of the ER Activities of 8 XTHER-infected Cell Lines
Measurements were made as described in Table 2 . has been a frequent source of difficulty in other systems. We have not tested the ability of our vector to infect a range of cell types in the present study, but in other studies we have succeeded in introducing this vector into a wide range of cell types, including cells of mouse, rat, mink, human, and bovine origin (23; unpublished results).
To approach an efficiency of infection of 100% requires a virus titer approaching 10 6 CFU/ml, since only a few milliliters of viral stock can normally be effectively applied to a tissue culture dish containing 10 6 cells. The virus-producing cell line described here, amXTHER, produced a titer of 5 x 10 5 CFU/ml, a titer in the required range. Further, we believe that by selecting individual clones for those with highest titer rather than using a pooled population of virus-producing cells, even higher titer stocks could be produced. Finally, physical concentration of retroviral vector stocks is possible (8) . Thus, the expected advantage of high efficiency gene introduction is realized in our system. The amount of virus stock that can be produced is almost unlimited, so that in our system we also are capable of infecting almost any desired number of cells as well.
Fourteen out of 14 infected clonal lines tested contained a single copy of the proviral genome of the vector, and thus the expected limited copy number was clearly obtained.
Finally, the percentage of rearranged proviruses observed (two out of 14; ~14%) is clearly low enough not to be a problem. It is, however, somewhat higher than we had expected. These deletions could have derived during three stages of our procedure. They could have been produced during transfections of the \p 2 cells, during infection of the PA317 cells, or during infection of the Rat 208F cells. Analysis of the DNA from the amXTHER cell line revealed no deletions (data not shown). However, since this cell line is polyclonal, a small proportion of deleted proviruses would not have been detected. It is possible that cloning of the am-XTHER cell line would result in a source of virus which would produce a lower fraction of deleted genomes in infected cells.
The bulk of the present study focused on ensuring that production of functional ER resulted from our vector. Because others have found that vectors which would be expected to produce two gene products frequently produce only one (12-15), we initially used Northern blot analysis to demonstrate that the expected 3.2 kb hER-encoding mRNA was produced at similar levels in eight of the eight cell lines tested. To see if this RNA was efficiently translated, we used a western dot blot to measure ER protein produced. By this assay, we were unable to detect statistically significant levels of ER in the infected cells, indicating that these cells had less than 7% of the ER of MCF7 cells. (Although not statistically significant, the data we obtained was consistent with the notion that the level of ER in these cells was a few percent of that present in MCF7). MCF7 cells contain a very high level of receptors, approximately 10,000 per cell, a level equivalent to that found in uterus (24) . Thus, our vector does not produce the high level of expression of receptor typical of uterus, but probably produces a level of expression more typical of other tissues. Whether this lower level of expression is appropriate in a given experiment will depend on the specific requirements of that experiment.
In order to demonstrate production of functional ER, we used an assay based on the ability of ER to stimulate transcription of genes containing an estrogen responsive element. Specifically, we made use of a plasmid containing an estrogen responsive CAT gene. We validated that this system could be used as a specific assay for exogenous ER by showing that the assay was dependent on an added ER gene in Rat 208F cells, that activity observed was dependent specifically on estrogen and that androgen or progesterone could not substitute. Using this assay, we demonstrated that eight of eight cell lines infected with our vector contained functional ER, whereas a cell line infected with the parental vector lacking the hER gene did not. In addition to validating our vector, these results confirm previously reported experiments (25) demonstrating that in introduction of an ER gene into a cell lacking receptor is sufficient to confer estrogen inducibility; that if other factors are required for this activity, they must be relatively broadly distributed among different cell types.
In constructing our hER transducing vector, we chose to start with the XT-1 vector for three reasons. 1) This vector contains the neo gene, providing a selectable marker for isolating and quantitating infected cells (11, 17) . 2. Expression of an introduced gene is under control of the tk promoter. Because this promoter is constitutive, expression of the exogenous gene should occur in a wide variety of cell types (26) . 3. Unlike some other promoters, the tk promoter has been shown to function well in mouse embryonic cells (26, 27) . This will allow us to both study the effects of constitutive ER expression in early stage mouse embryos as well as to generate transgenic animals which constitutively express this receptor.
MATERIALS AND METHODS
Plasmids
pXT1 (17), a plasmid containing the genome of the retroviral vector XT1, was provided by Dr. E. F. Wagner (European Molecular Biology Laboratory, Heidelberg, FRG). Our source of the cloned hER gene was a plasmid we designated pHER91023 which was generated by Dr. M. J. Tsai (Baylor College of Medicine, Houston, TX). The 2092 bp EcoRI fragment of XOR8 (5) was isolated and inserted into the EcoRI site of the expression vector p91023(B) (28) . XOR8, a recombinant phage containing the cloned cDNA of the human estrogen receptor gene, was obtained from Dr. G. L. Greene (The University of Chicago, Chicago, IL). The plasmid pBLCAT2 (Fig. 1B) , which contains the CAT gene under the control of tk promoter, was obtained from Dr. B. Luckow (Deutsches Krebsforschungszentrum, Heidelberg, FRG) (29) . The plasmid which we designate pERE-BLCAT2 (Deutsches Krebsforschungszentrum, Heidelberg, FRG) (Fig. 1B) is a derivative of pBLCAT2 containing a 27 bp estrogen responsive element inserted at nucleotide-105 (7) and was provided by Dr. M. J. Tsai.
pXTHER was generated by digesting pHER91023 with EcoRI, isolating the 2092 bp fragment containing the intact hER cDNA, filling in the ends to make them blunt, ligating BamHI linkers to these blunt ends, digesting with SamHI, and ligating the resulting DNA to Sg/ll-digested pXT-1. A clone containing the hER sequences in the same transcriptional orientation as the XT1 vector was isolated (Fig. 1 A) .
Cell Culture
NIH 3T3 cells (30) and rat 208F cells (31) (19) . Cells were grown in Dulbecco's nr.odified Eagle medium containing 10% heat-inactivated fetal calf serum in 5% CO 2 at 37 C, except X 2 cells for which this medium was altered by substitution of 10% calf serum for 10% fetal calf serum.
Production of Virus-Producing Cell Lines
The procedure we used has previously been described (32) . Briefly, fa packaging cells were plated at 3 x 10 5 cells/60-mm dish 24 h before transfection. Ten micrograms of pXTHER were transfected onto the packaging cells by the calcium phosphate precipitation method (33) . Two days post transfection, the supernatant was harvested, passed through a 0.45 ftM filter (Millipore, Bedford, MA) and a small volume of the supernatant (about 0.1 ml) was used to infect PA317 packaging cell in the presence of 4 ng/vn\ polybrene (Aldrich, Milwaukee, Wl). The infection lasted about 16-18 hours and G418 selection (300 ^g/ml active G418) started after the infection. The G418-resistant colonies were observed 10-14 days after the selection and were pooled as virus-producer cell, amXTHER, for subsequent experiments.
Titer Determination
Supernatant was harvested from amXTHER 18 h after a change of medium for use as a viral stock. The viral titer was determined by a serial dilution of viral stock, followed by infection of 10 5 NIH3T3 cells/600-mm dish in the presence of 4 Mg/ml polybrene. G418-containing medium (300 ng/m\ active G418) was added 18 h after the infection and the G418-resistant colonies were scored by staining the cells with 0.1% methylene blue in methanol/water (1:1) (34).
Nucleic Acid Analysis
High molecular weight DNA was isolated from cultured cells as previously described (35) . Samples were digested to completion with an appropriate restriction enzyme for 6-8 h at 37 C. Ten micrograms of genomic DNA was loaded and electrophoretically fractionated in 1 % agarose gel. After transfer to nitrocellulose paper the immobilized DNA was hybridized to the DNA probe which was 32 P-labeled by the multiprimer labeling system (Amersham, Arlington Heights, IL) (36) . The conditions used for hybridization have been described (37) .
Total cellular RNa was prepared as previously described (35) . Fifteen micrograms of total cellular RNA were denatured with glyoxal and dimethyl sulfoxide (37), loaded, and electrophoresed through a 1.2% agarose gel, transferred to nitrocellulose paper and hybridized with the DNA probe (37) . The hybridization conditions have also been described (37) .
Western Dot Blots
Nuclear and cytoplasmic fractions were prepared from 10 7 cells (38) . In our experiments, no significant amounts of hER were detected in cytoplasm, and the values from nuclear extracts only were used. Amounts of extracts containing 10 and 50 fig protein were spotted onto nitrocellulose membranes using a Schleicher & Schuell (Keene, NH) dot blot apparatus using the techniques recommended by the supplier. In the case of MCF7, 50/^ protein were found to saturate the assay and the value obtained from 10 ^g protein was used. In all other cases, the value obtained from 50 ng protein was used.
All subsequent steps were performed at room temperature. All incubations were done with continuous agitation. For each incubation, a volume of solution just sufficient to wet the filter was used. Filters were incubated in TS/C (100 IDM TrisHCI, pH 8, 150 rriM NaCI, 1 % nonfat milk powder) for 2 h. This buffer was replaced with TS/C containing 0.6 ^g/ml monoclonal antibody H226 (39) and the filter was incubated for 2 h. The filter was washed three times with 20 ml TS/C for 15 min each time. A volume of TS/C containing 0.4 ^g/ml rabbit antirat antibody (Zymed, South San Francisco, CA) sufficient to barely wet the filter was added and the filter was incubated for 1 h. The filter was washed three times as above. The filter was incubated TS/C containing 10 6 CPM/ml of [ 12S I] Protein A (30 nC\/(ig) for 1 h. The filter was washed three times as above, air dried, and exposed to Kodak XAR-5 film overnight.
CAT Assay
Cells to be assayed were split 24 h before transfection at a density of 5 x 10 5 cells/60 mm dish. Five micrograms of plasmid DNA were transfected onto the cells by calciumphosphate precipitation technique (33) . The cells were then cultured for 48 h in the medium with 1 x 1O~8 M 17/3-estradiol or without hormone (dextran-charcoal stripped serum) (22) . The cell extracts of soluble protein (100 ^g) were assayed for CAT activity as previously described (20) . To quantify the activities, radioactive sports were excised from the silica plates and their 14 C content was measured by liquid scintillation counting.
